Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 315-321 , March 2003

Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope

Received 15 May 2002 ,Accepted 28 September 2002.

References 

  1. Fenton AM, Hammil SC, Rea R, et al.  Vasovagal syncope. Ann Intern Med. 2000;133:714–725
  2. Mosqued-Garcia R, Furlan R, Tank J, et al.  The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898–2906
  3. Grubb BP, Kosinski DJ. Serotonin and syncope: an emerging connection?. Eur J Cardiac Pacing Electrophysiol. 1995;5:306–313
  4. Theodorakis GN, Markianos M, Zarvalis E, et al.  Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syncope. J Am Coll Cardiol. 2000;36:174–178
  5. Wallbridge DR, MacIntyre HE, Gray CE, et al.  Increase in plasma beta endorphins precedes vasodepressor syncope. Br Heart J. 1994;71:597–599
  6. Dietz NM, Halliwill JR, Spielmann JM, et al.  Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol. 1997;82:1785–1793
  7. Jardine DL, Melton IC, Crozier IG, et al.  Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol. 1997;79:1302–1306
  8. Mittal S, Stein KM, Markowitz SM, et al.  Induction of neurally mediated syncope with adenosine. Circulation. 1999;99:1318–1324
  9. Rokaeus A. Galanin, a newly isolated biological active neuropeptide. Trends Neurosci. 1987;10:158–164
  10. Michener SR, Aimone LD, Yaksh TL, et al.  Distribution of galanin-like immunoreactivity in the pig, rat and human central nervous system. Peptides. 1990;11:1217–1223
  11. Vrontakis ME, Torsello A, Friesen HG. Galanin. J Endocrinol Invest. 1991;14:785–794
  12. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and humans. Endocrine Rev. 1998;19:717–797
  13. Giustina A, Licini M, Schettino M, et al.  Physiological role of galanin in the regulation of anterior pituitary function in humans. Am J Physiol. 1994;266:E57–E61
  14. Crawley JN. The role of galanin in feeding behavior. Neuropeptides. 1999;33:369–375
  15. Diaz-Cabiale Z, Narvaez JA, Yanaihara N, et al.  Galanin/alpha2-receptor interactions in central cardiovascular control. Neuropharmacology. 2000;39:1377–1385
  16. Hökfelt T, Xu ZQD, Shi TJ, et al.  Galanin in ascending systems: focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann NY Acad Sci. 1998;863:252–263
  17. Ulman LG, Evans HF, Iismaa TP, et al.  Effect of human, rat and porcine galanins on cardiac vagal action and blood pressure in the anaesthetized cat. Neurosci Lett. 1992;136:105–108
  18. Shih CD, Chan SHH, Chan JYH. Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Brain Res. 1997;721:76–82
  19. degli Uberti EC, Ambrosio MR, Bondanelli M, et al.  Human galanin reduces plasma norepinephrine levels in man. J Clin Endocrinol Metab. 1995;80:1894–1898
  20. degli Uberti EC, Ambrosio MR, Bondanelli M, et al.  Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man. Eur J Endocrinol. 1995;133:723–728
  21. degli Uberti EC, Bondanelli M, Margutti A, et al.  The acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide. Neuroendocrinology. 1996;64:398–404
  22. Brignole M, Alboni P, Benditt D, et al.  Giudelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001;22:156–1306
  23. Kenny RA, Bayliss J, Jngram A, et al.  Head up tilt test: A useful test for investigating unexplained syncope. Lancet. 1986;1:1352–1354
  24. Sutton R, Petersen M, Brignole M, et al.  Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol. 1992;3:180–183
  25. Matzen SH. Neuroendocrine mechanisms during reversible hypovolemic shock in humans with emphasis on the hystaminergic and serotonergic system. Acta Physiol Scand. 1995;628(suppl):6–31
  26. Smith GDP, Watson LP, Mathias CJ. Cardiovascular and catecholamine changes induced by supine exercise and upright posture in vasovagal syncope: comparison with normal subjects and subjects with sympathetic denervation. Eur Heart J. 1996;17:1882–1890
  27. Shen WK, Low PA, Rea RF, et al.  Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population. J Am Coll Cardiol. 2000;35:1470–1477
  28. Dunning BE, Havel PJ, Veith RC, et al.  Pancreatic and extrapancreatic galanin release during sympathetic neural activation. Am J Physiol. 1990;258:E436–E444
  29. Havel PJ, Mundinger TO, Veith RC, et al.  Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs. Am J Physiol. 1992;263:E8–E16
  30. Yuan C-S, Xie J-T, Aung HH. Gastric effects of galanin and its interaction with leptin on brainstem neuronal activity. J Pharmacol Exp Ther. 2002;301:488–493
  31. Giustina A, Brogan R, Conley L, et al.  Acute and chronic galanin administration decreased hypothalamic galanin synthesis in both male and female adult rats: evidence for a long-loop galanin autofeedback. Metabolism. 2000;49:778–783
  32. Carey DG, Iismaa TP, Ho KY, et al.  Potent effects of human galanin in man: Growth hormone secretion and vagal blockade. J Clin Endocrinol Metab. 1993;77:90–93
  33. Potter E. Cardiovascular actions of galanin. Ann NY Acad Sci. 1998;863:170–174
  34. Mundinger TO, Taborsky GJ. Differential action of hepatic sympathetic neuropeptides: Metabolic action of galanin, vascular action of NPY. Am J Physiol Endocrinol Metab. 2000;278:E390–E397
  35. Houston DS, Vanhoutte PM. Serotonin and the vascular system: Role in health and disease, implications for therapy. Drugs. 1986;31:149–163
  36. Ramage AG. Influence of 5-HT1A receptor agonists on sympathetic and parasympathetic nerve activity. J Cardiovasc Pharmacol. 1990;15(suppl 7):75–85
  37. Theodorakis GN, Markianos M, Livanis EG, et al.  Central serotonergic responsiveness in neurocardiogenic syncope: A clomipramine test challenge. Circulation. 1998;98:2724–2730
  38. Fuxe K, Jansson A, Diaz-Cabiale Z, et al.  Focus on galanin and galanin fragment/ 5-hydroxytryptamine1A receptor interactions in the brain. Ann NY Acad Sci. 1998;863:274–290
  39. Ögren SO, Schott PA, Kehr J, et al.  Modulation of acetylcholine and serotonin transmission by galanin: Relationship to spatial and adversive learning. Ann NY Acad Sci. 1998;863:342–363
  40. Alboni P, Bondanelli M, Dinelli M, et al.  Role of serotonergic system in the genesis of vasovagal system. Europace. 2000;2:172–180

☆ Supported by grants from the Italian Ministry of University and Scientific and Technological Research (60%, 2002), and the Associazione Ferrarese dell'Ipertensione Arteriosa.

☆☆ Address reprint requests to Ettore C. degli Uberti, MD, Department of Biomedical Sciences and Advanced Therapies, Section of Endocrinology, University of Ferrara, Via Savonarola, 9, 44100 Ferrara, Italy.

PII: S0026-0495(02)05267-8

doi: 10.1053/meta.2003.50051

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 315-321 , March 2003

Article Tools